Applications open until March 31, 2025<\/p>\n\n\n\n\n\n\n\n
We are pleased to announce that until March 31, 2025<\/strong> the c<\/strong>alls for the Marcucci and Fabbrizzi Prizes 2024<\/strong>, supported by Kedrion<\/strong> and made in collaboration with Fondazione Carlo Erba<\/strong>, are open.<\/p>\n\n\n\n The Marcucci Prize<\/strong>, established in memory of Kedrion’s founder, Guelfo Marcucci, is aimed at young researchers who have demonstrated exceptional commitment and results in the field of hematology. The two research projects that will best prove to be particularly innovative and that could form the basis for future programs on the topic of congenital coagulopathies<\/strong> will be selected. The two prizesamount to 10,000 euro each and are reserved for graduates in scientific disciplines.<\/p>\n\n\n\n The Fabbrizzi Prize<\/strong>, promoted to pay homage to the work of Fabrizio Fabbrizzi, a physician and researcher at Kedrion who passed away in 2020, is aimed at young Italian graduates. The best research project on the therapeutic use of plasma proteins, their purification from plasma or production with genetic engineering techniques<\/strong> will be selected. The call is valued at 7,500 euro and is also reserved for graduates in scientific subjects. <\/p>\n\n\n\n These prizesaim to promote excellence in scientific research<\/strong>, offering unique opportunities to young talent. Kedrion<\/strong> is proud to collaborate with Fondazione Carlo Erba<\/strong> to support innovation in the field of biomedicine<\/strong>.<\/p>\n\n\n\n \u201cThe final objective of these initiatives that aim to involve mainly young Italian researchers \u2013 said Andrea Caricasole, Chief Research and Innovation Officer at Kedrion<\/strong> \u2013 is to support and incentivize new discoveries, particularly in the field of rare and ultra-rare diseases, which can have a significant impact on human health\u201d. \u201cWe want to encourage the development of solutions that can improve the quality of life and contribute to the progress of medical science, particularly through the therapeutic use of plasma proteins, an area in which Kedrion is specialized.\u201d<\/p>\n\n\n\n